125PD FINAL REPORT OF A RANDOMIZED PHASE II STUDY OF DOCETAXEL/OXALIPLATIN (DO) AND DOCETAXEL (D) IN PREVIOUSLY TREATED NON-SMALL CELL LUNG CANCER (NSCLC) PATIENTS (PTS). AN ALPE-ADRIA THORACIC ONCOLOGY MULTIDISCIPLINARY GROUP STUDY (ATOM 019)

Lung Cancer ◽  
2009 ◽  
Vol 64 ◽  
pp. S53
Author(s):  
O. Belvedere ◽  
A. Follador ◽  
C. Rossetto ◽  
A.M. Sibau ◽  
S. Rizzato ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Phase Ii Study ◽  
Small Cell ◽  
Final Report ◽  
Small Cell Lung ◽  
Randomized Phase Ii ◽  
Previously Treated ◽  
Multidisciplinary Group ◽  
Nsclc Patients

Phase II study of a novel taxane (Cabazitaxel-XRP 6258) in previously treated advanced non-small cell lung cancer (NSCLC) patients

2016 ◽  
Vol 78 (3) ◽  
pp. 509-515 ◽  
Author(s):  
Ankit Madan ◽  
Benjamin S. Jones ◽  
Rodolfo Bordoni ◽  
Mansoor N. Saleh ◽  
Mary S. Jerome ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Phase Ii ◽  
Cell Lung Cancer ◽  
Phase Ii Study ◽  
Small Cell ◽  
Small Cell Lung ◽  
Previously Treated ◽  
Nsclc Patients
Sign in / Sign up

Export Citation Format

Share Document